" quote "
Pancreatic cancer is another one which has a particularly poor prognosis and there’s
a form of breast cancer called triple negative breast cancer which doesn’t respond particularly well to any of the therapies. If you look at all of these very difficult to treat indications it would be hard to model them but the model would be of the order of billions of dollars
Are you saying that your treatment, your platform, DX1, can treat those or you’re not sure, you think it will?
I’m saying that in pre-clinical studies we’ve certainly got very positive signals both in glioblastoma and in
triple negative breast.
Well sounds to me like were on track for a good announcement this month!
Didnt realise how much more significant triple neg breast cancer is too.
Very informative information
Thanks
@Hsinvest for the content!
